OHI Stock Cash Flow Statements

Omega Healthcare Investors Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Omega Healthcare Investors Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31

cash flows from operating activities
net income	140,479,000	112,060,000	116,465,000	114,914,000	117,079,000	69,346,000	56,522,000	93,908,000	61,521,000	36,845,000	46,706,000	105,064,000	91,915,000	195,156,000	34,238,000	61,146,000	142,948,000	75,671,000	72,182,000	64,903,000	59,062,000	81,986,000	87,933,000	65,156,000	-137,515,000	68,157,000	109,112,000	129,883,000	82,134,000	113,154,000	58,196,000	63,543,000	83,254,000	43,466,000	43,052,000	56,990,000	61,713,000	46,817,000	55,829,000	47,206,000	38,137,000	49,058,000	38,120,000	33,923,000	30,119,000	30,572,000	26,084,000	19,293,000	21,436,000	17,790,000	-5,913,000	4,969,000	17,007,000	15,509,000	20,951,000	16,239,000	21,138,000	19,822,000	24,912,000	15,709,000	28,072,000	17,122,000	17,234,000	17,316,000	15,349,000	16,050,000	20,659,000	13,409,000	24,146,000	11,261,000	6,881,000	20,007,000	5,120,000	2,257,000	9,304,000
adjustment to reconcile net income to net cash from operating activities:
depreciation and amortization	80,509,000	79,875,000	78,612,000	77,245,000	74,234,000	74,557,000	75,674,000	80,798,000	82,018,000	81,192,000	83,739,000	82,709,000	83,207,000	82,752,000	85,269,000	80,498,000	76,696,000	73,637,000	70,852,000	70,598,000	70,711,000	69,609,000	70,361,000	75,323,000	71,925,000	70,350,000	69,993,000	70,808,000	68,316,000	65,505,000	62,433,000	60,794,000	60,143,000	59,156,000	30,610,000	30,401,000	30,111,000	31,301,000	31,444,000	32,260,000	32,202,000	32,225,000	31,959,000	30,332,000	28,305,000	27,199,000	27,147,000	25,489,000	24,871,000	24,759,000	25,218,000	25,743,000	27,742,000	16,451,000	14,687,000	11,680,000	11,093,000	10,990,000	10,931,000	10,705,000	10,076,000	9,713,000	9,396,000	9,288,000	9,138,000	8,831,000	8,799,000	8,831,000	8,363,000	7,542,000	7,527,000	6,209,000	6,275,000	6,540,000	6,253,000
impairment on real estate properties	14,215,000	1,235,000	1,737,000	8,620,000	8,182,000	5,292,000	3,951,000	27,890,000	21,114,000	38,988,000	17,230,000	10,015,000	7,695,000	3,511,000	2,205,000	35,719,000	5,659,000			3,154,000	22,868,000																							0	0	0	272,000	1,373,000
straight-line rent and other write-offs	17,537,000	10,000,000
provision (recovery) for credit losses						8,470,000								1,824,000
amortization of deferred financing costs and loss on debt extinguishment	1,016,000	1,380,000	1,562,000	2,050,000	3,575,000	4,959,000	4,191,000	3,488,000	3,251,000	3,259,000	3,251,000	3,629,000	3,258,000	3,199,000	3,219,000
stock-based compensation expense	9,234,000	15,812,000	9,198,000	9,083,000	9,188,000	9,227,000	8,762,000	8,756,000	8,806,000	8,744,000	6,787,000	6,809,000	6,846,000	6,860,000	4,502,000	3,840,000	2,921,000	4,040,000	4,558,000	3,880,000	3,962,000	4,089,000	4,056,000	3,862,000	3,872,000	3,734,000	3,744,000
gain on assets sold – net			-1,886,000	238,000	-12,911,000	1,391,000	-9,712,000	-44,076,000	-12,243,000	-13,637,000	-180,204,000	-40,930,000	-25,180,000	-113,637,000	-975,000	-2,893,000	-53,067,000			-15,526,000	5,361,000	2,891,000	-17,500,000	-46,421,000	-693,000	622,000	-7,420,000	-30,277,000	-5,139,000	-13,221,000	-1,571,000								-2,883,000	0	0				-1,689,000							0					0
straight-line rent and effective interest receivables	-10,943,000	-12,583,000	-13,720,000	-11,441,000	-8,656,000	-9,201,000	-10,435,000	-8,157,000	-10,681,000	-12,576,000
interest paid-in-kind	-2,525,000	-2,471,000	-2,420,000	-2,369,000	-3,099,000	-3,575,000	-3,373,000	-2,771,000	-2,666,000	-2,555,000	-2,444,000	-2,468,000	-2,315,000	-2,196,000	-2,074,000	-1,891,000	-2,066,000	-1,757,000	-1,446,000	-1,416,000	-1,451,000	-1,602,000	-1,891,000
income from unconsolidated joint ventures					790,000	827,000					3,056,000	-1,098,000
other non-cash items	-4,613,000	255,000
change in operating assets and liabilities – net:
contractual receivables	2,484,000	-1,425,000	-2,274,000	23,000	491,000	915,000	-2,377,000	-673,000	-790,000	180,000	1,718,000	411,000	2,814,000	-1,912,000	-16,919,000	-5,775,000	-1,744,000	1,108,000	480,000	103,000	702,000	6,193,000	-4,630,000	-1,203,000	-2,125,000
lease inducements	253,000	-9,750,000	-760,000	234,000	232,000	233,000	-3,240,000	176,000	177,000	-12,323,000	177,000	1,915,000	1,933,000	1,932,000	-18,289,000	-14,718,000	-11,859,000	-5,499,000	-9,995,000	-423,000	-764,000	838,000	-32,389,000	-9,761,000	447,000	448,000	447,000	647,000	648,000	647,000	647,000	647,000			-2,110,000	647,000	647,000	647,000	715,000
other operating assets and liabilities	16,089,000	-7,332,000	33,165,000	1,400,000	9,665,000	-10,470,000	14,754,000	1,535,000	6,718,000	-19,232,000	21,281,000	-2,232,000	9,921,000	-22,498,000	14,134,000	993,000	-11,718,000	4,634,000	-23,211,000	14,039,000	-10,951,000	12,539,000	-50,506,000	8,672,000	-4,233,000	12,986,000	-34,653,000	9,355,000	17,698,000	-4,066,000	-19,989,000	1,469,000	-6,253,000	-1,594,000	23,819,000	-3,480,000	9,828,000	7,752,000	-2,563,000	5,163,000	11,860,000	-764,000	-8,231,000	-7,207,000	11,442,000	-3,814,000	-324,000	-4,270,000	5,887,000	-6,389,000	-2,829,000	3,894,000	867,000	-5,490,000	3,491,000		2,602,000	2,947,000	4,568,000
net cash from operating activities	239,265,000	181,952,000	228,968,000	184,885,000	184,103,000	151,474,000	164,980,000	171,020,000	170,376,000	111,360,000	153,682,000	166,849,000	172,994,000	132,202,000	156,529,000	147,992,000	140,343,000	155,337,000	110,075,000	150,908,000	131,299,000	164,266,000	52,900,000	147,651,000	164,675,000	151,648,000	113,938,000	168,554,000	170,342,000	159,716,000	127,179,000	141,081,000	129,712,000	89,798,000	103,294,000	77,946,000	92,839,000	88,699,000	78,056,000	79,899,000	78,722,000	63,728,000	57,600,000	51,304,000	62,543,000	44,880,000	49,544,000	40,753,000	51,866,000	38,446,000	38,706,000	47,119,000	44,506,000	27,141,000	38,797,000	32,788,000	33,498,000	35,540,000	45,397,000	29,184,000	5,509,000	26,158,000	28,477,000	17,568,000	24,327,000	21,391,000	21,256,000	14,796,000	5,332,000	17,812,000	24,871,000	17,773,000	20,851,000	11,818,000	22,515,000
cash flows from investing activities
acquisition of real estate	-502,057,000	-58,365,000	-178,825,000	-101,830,000	-114,711,000	-13,262,000	-51,237,000	-56,289,000	-128,544,000	-26,383,000	-88,626,000	-28,193,000	-11,000	-113,157,000	34,000	-346,554,000	-24,890,000			-52,375,000	0	-23,072,000	-29,672,000		-214,291,000	-123,403,000	-7,574,000																																	-19,525,000	-40,000,000	-48,035,000	-5,200,000	0								-128,008,000	0	-62,643,000	-58,053,000
net proceeds from sale of real estate investments	62,114,000	120,881,000	26,288,000	23,863,000	34,805,000	10,089,000	323,743,000	199,004,000	44,725,000	17,559,000	320,768,000	51,418,000	54,309,000	332,552,000	7,680,000	33,251,000	176,963,000	8,692,000	356,000	63,235,000	24,399,000	147,207,000	74,745,000
investments in construction in progress	-14,650,000	-15,081,000	-9,688,000	-17,143,000	-27,643,000	-14,506,000	-15,427,000	-14,387,000	-9,901,000	-4,780,000	-4,377,000	-4,775,000	-3,311,000	-4,667,000	-3,141,000	-41,491,000	-23,161,000	-44,175,000	-30,851,000	-40,681,000	-35,447,000	-41,458,000	-21,855,000	-17,280,000	-23,301,000	-30,405,000	-15,703,000
investment in loan receivables and other	-68,656,000	-41,111,000
collection of loan principal	37,540,000	62,757,000	94,065,000	48,117,000	51,093,000	14,342,000	29,228,000	14,045,000	69,907,000	52,011,000
investments in unconsolidated joint ventures	-236,000	-1,014,000	-573,000	-80,000	-257,000	-61,000	-172,000	-3,983,000			0	0			0
distributions from unconsolidated joint ventures in excess of earnings	310,000	1,156,000	-1,818,000	1,585,000	308,000	942,000	5,791,000	1,882,000	752,000	382,000	1,993,000	159,000	1,115,000	61,000	197,000	1,004,000	5,986,000
capital improvements to real estate investments	-12,768,000	-20,173,000	-15,479,000	-8,268,000	-7,069,000	-6,941,000	-14,706,000	-10,114,000	-7,851,000	-5,340,000	-9,500,000	-11,461,000	-12,712,000	-13,548,000	-15,993,000	-13,352,000	-14,936,000	-14,405,000	-10,199,000	-5,399,000	-5,242,000	-9,587,000	-9,596,000	-12,473,000	-8,432,000	-8,662,000	-8,199,000	-9,063,000	-9,596,000	-12,268,000	-9,544,000	-8,243,000			-5,604,000	-5,233,000	-4,322,000	-5,028,000	-3,334,000		-6,425,000
proceeds from derivative instruments							0	0
receipts from insurance proceeds	70,000	322,000	1,418,000	0	30,000	1,627,000	725,000	2,316,000	3,269,000	448,000	593,000	93,000	543,000	22,000	45,000	1,292,000	1,044,000	4,458,000	1,376,000	1,806,000	10,000	5,811,000	1,090,000
net cash from investing activities	-463,547,000	19,261,000	-281,734,000	-133,458,000	-208,518,000	-47,454,000	111,324,000	72,575,000	-187,326,000	2,657,000	170,432,000	-4,745,000	99,828,000	177,338,000	-72,021,000	-450,484,000	86,543,000	-87,138,000	72,126,000	-22,667,000	-144,302,000	-4,803,000	-1,447,000	114,915,000	-264,195,000	-152,204,000	16,351,000	20,957,000	-425,897,000	-35,188,000	-673,780,000	-46,660,000			-18,527,000	-86,981,000	-20,671,000	-319,910,000	-120,383,000	-529,036,000	-24,838,000	-33,501,000	-11,456,000	-162,516,000	-210,834,000	-27,385,000	10,032,000	-237,614,000	-6,697,000	-7,662,000	-5,667,000	-26,030,000	-8,868,000	-336,975,000	-22,942,000	-195,292,000	-6,669,000	-7,004,000	-39,000	-28,828,000	-17,551,000	-131,210,000	-9,510,000	2,741,000	-31,185,000	-4,548,000	3,086,000					-154,294,000	12,824,000	-61,996,000	8,125,000
cash flows from financing activities
proceeds from long-term borrowings			0	179,319,000			0	427,072,000			0	82,195,000	95,000,000	420,208,000	55,000,000
payments of long-term borrowings	-126,640,000	-400,600,000	-2,513,000	-252,660,000	-848,250,000	-41,878,000	-227,741,000	-421,249,000	-84,088,000	-1,913,000	-1,898,000	-112,508,000	-407,990,000	-66,896,000	-56,882,000																																																									-79,318,000
payments of financing related costs			-115,000	-5,011,000	-609,000	-1,283,000	-494,000	-3,327,000	0	-6,000	0	-376,000	-7,000	-6,000	-55,000	-733,000						0	-8,000	0	-715,000	-27,920,000	-563,000	-60,000	-8,189,000	-5,000	-3,576,000	-24,012,000			-21,318,000	-397,000	-4,579,000	-8,585,000	-4,155,000	-2,181,000	-21,000	-226,000	-806,000	-3,974,000	-230,000	-403,000	-12,517,000
net proceeds from issuance of common stock	257,128,000	260,723,000	434,434,000	526,037,000	242,836,000	32,350,000	8,658,000	126,133,000	199,626,000	1,985,000	2,287,000	2,334,000	2,344,000	1,147,000	1,582,000	297,819,000	4,175,000			48,330,000	-307,000			-76,000	15,562,000	-125,000	6,759,000					-416,000	-298,000	17,000	440,019,000	-16,000	4,845,000	29,334,000	27,818,000	118,214,000	61,895,000	46,811,000	51,453,000	-55,000	62,099,000	10,404,000	5,170,000	-27,000	-113,000	3,242,000	28,108,000	1,847,000	63,409,000	36,786,000	36,739,000	-75,000
dividends paid	-194,567,000	-189,218,000	-181,447,000	-173,278,000	-165,962,000	-164,758,000	-164,566,000	-164,485,000	-157,437,000	-157,379,000	-157,336,000	-157,288,000	-157,628,000	-160,641,000	-160,580,000	-146,875,000	-143,441,000	-137,178,000	-136,633,000	-132,958,000	-132,717,000	-131,572,000	-131,449,000	-129,179,000	-126,702,000	-124,450,000	-122,272,000	-119,489,000	-116,595,000	-109,568,000	-107,500,000	-105,127,000			-68,261,000	-67,232,000	-65,777,000	-63,822,000	-61,670,000	-59,043,000	-55,063,000	-53,431,000	-50,579,000	-49,512,000	-45,661,000	-44,437,000	-42,580,000	-41,438,000	-41,411,000	-38,776,000	-40,268,000	-39,811,000	-36,420,000	-32,053,000	-30,599,000	-27,855,000	-27,301,000	-27,044,000	-27,035,000	-27,041,000	-25,267,000	-23,316,000	-22,439,000	-21,602,000	-20,917,000	-20,635,000	-18,106,000					-13,835,000	-13,780,000	-10,762,000	-17,372,000
net payments to noncontrolling members of consolidated joint venture			0	0			0	4,000
redemption of omega op units							0	0												-16,000	0			0	0
distributions to omega op unit holders	-7,453,000	-18,603,000	-6,266,000	-6,276,000	-6,260,000	-10,452,000	-5,646,000	-5,984,000	-5,636,000	-9,131,000	-5,080,000	-5,080,000	-5,062,000	-5,276,000	-5,124,000	-4,208,000	-4,953,000	-5,120,000	-7,013,000	-5,848,000	-5,880,000			-5,807,000	-5,676,000
net cash from financing activities	588,955,000	-347,698,000	243,409,000	268,131,000	-299,200,000	-186,021,000	-389,789,000	-41,836,000	124,737,000	-166,422,000	-161,973,000	-190,718,000	-597,993,000	161,237,000	-166,138,000	292,279,000	-218,474,000	-75,174,000	-152,590,000	-127,595,000	10,950,000	-224,517,000	-69,539,000	-203,824,000	102,560,000	-18,762,000	-183,789,000	-128,406,000	254,892,000	-100,879,000	550,689,000	-104,202,000			610,887,000	13,072,000	-100,405,000	239,526,000	60,085,000	383,996,000	6,834,000	-48,799,000	-22,244,000	105,972,000	152,381,000	-17,351,000	-57,210,000	186,482,000	-39,435,000	-29,169,000	-36,579,000	-15,360,000	-36,403,000	236,597,000	57,169,000	164,028,000	-31,106,000	-33,828,000	-35,352,000	-3,937,000	13,667,000	105,701,000	-19,430,000	-18,938,000	4,982,000	-17,014,000	-22,416,000	-19,492,000				139,701,000	-33,441,000	40,866,000	-32,877,000
effect of foreign currency translation on cash, cash equivalents and restricted cash	3,839,000	1,822,000	-2,218,000	1,621,000	-280,000	297,000	298,000	-353,000	206,000	279,000	325,000	-1,672,000	-1,146,000	-407,000	36,000	1,361,000	-318,000	-287,000	118,000	-114,000	-357,000	-496,000	377,000
increase in cash, cash equivalents and restricted cash			188,425,000				-113,187,000	201,406,000	107,993,000	-52,126,000	162,466,000	-30,286,000	-326,317,000	470,370,000	-81,594,000	-8,852,000	8,094,000	-7,262,000	29,729,000
cash, cash equivalents and restricted cash at beginning of period	0	548,735,000	0	0	0	444,730,000	0	0	0	300,644,000	0	0	0	24,411,000	0		0	0	11,671,000		0	0	96,808,000
cash, cash equivalents and restricted cash at end of period	368,512,000	404,072,000	188,425,000	321,179,000	-323,895,000	363,026,000	-113,187,000	201,406,000	107,993,000	248,518,000	162,466,000	-30,286,000	-326,317,000	494,781,000	-81,594,000		8,094,000	-7,262,000	41,400,000		-2,410,000	-65,550,000	79,099,000
benefit from credit losses		5,092,000					32,913,000	2,733,000			64,296,000	4,106,000			49,710,000
(gain) loss on assets sold – net		-10,075,000																																		0											-5,316,000	133,000
(income) income from unconsolidated joint ventures		-121,000												-677,000	-530,000
acquisition deposit		-30,111,000															2,482,000
proceeds from net investment hedges			0	0	0	8,429,000
decrease in cash, cash equivalents and restricted cash		-144,663,000			-323,895,000	-81,704,000															-2,410,000	-65,550,000	-17,709,000
benefit from rental income			3,038,000				0	7,232,000	901,000	12,500,000	96,133,000	13,820,000	11,654,000	3,151,000	16,449,000	150,000	3,011,000
(recovery) benefit from credit losses			-720,000	-9,061,000						-4,057,000
accretion of direct financing leases			42,000	36,000	36,000	34,000	34,000	27,000	27,000	26,000	26,000	19,000	19,000	19,000	18,000	7,000	-3,000	-1,000	10,000	20,000	22,000	34,000	33,000	32,000	25,000	-3,148,000	-3,016,000	-3,158,000	-3,084,000	-2,994,000	-2,921,000	-2,883,000			-2,614,000	-2,545,000	-2,478,000	-2,414,000	-2,350,000
amortization of acquired in-place leases – net			651,000	-1,275,000	-531,000	-531,000	-539,000	-2,136,000	-644,000	-6,131,000	-2,102,000	-976,000	-976,000	-1,608,000	-1,064,000	-1,231,000	-1,287,000	-1,560,000	-1,826,000
placement of loan principal			-197,122,000	-79,702,000	-145,074,000	-48,113,000	-177,999,000	-59,899,000	-151,488,000	-31,240,000
repurchase of common stock											0	0	-114,946,000	-27,321,000
recovery on direct financing leases
loss (income) from unconsolidated joint ventures							-2,145,000	2,290,000	-100,000	137,000
acquisition deposit – net
proceeds from sale of direct financing lease and related trust															0	5,000,000	0
noncontrolling members’ contributions to consolidated joint venture										22,000	54,000	5,000	0	22,000
effective yield payable (receivable) on mortgage notes															441,000
straight-line rent receivables											-6,481,000	-14,533,000	-15,893,000	-24,137,000	-13,805,000	-10,988,000	-11,510,000	-12,790,000	-11,292,000	-14,772,000	-16,041,000	-16,249,000	-14,497,000	-11,681,000	9,615,000	-11,427,000	-11,747,000	-12,132,000	-12,203,000	-7,809,000	-9,947,000	-9,492,000			-5,275,000	-5,037,000	-5,218,000	-5,377,000	-5,324,000
acquisition of a business, net of cash acquired																0	0
acquisition deposit - net
effective yield payable on mortgage notes												589,000	485,000	463,000
placement of mortgage loans												-3,912,000	-2,317,000	-2,801,000	-2,652,000	-5,963,000	-5,069,000	-4,425,000	-5,245,000	-3,155,000	-5,241,000	-50,195,000	-6,749,000	-5,319,000	-4,346,000	-19,229,000	-5,749,000	-20,827,000	-15,367,000	-6,366,000	-6,162,000	-6,441,000			-2,002,000	-768,000	-437,000	-415,229,000	-113,114,000	-151,000	-358,000	-820,000	-2,049,000	-4,843,000	-2,171,000	-3,646,000	-1,309,000	-119,581,000	-5,854,000	-2,858,000	-1,749,000	-18,285,000								0	0			0	0	0	-345,000
collection of mortgage principal												47,896,000	116,352,000	22,913,000	1,128,000	11,150,000	854,000	42,036,000	489,000	476,000	436,000	379,000	24,797,000	471,000	385,000	340,000	333,000	1,826,000	16,098,000	41,739,000	312,000	334,000	-710,000	1,447,000	288,000	279,000	5,183,000	117,390,000	132,000		121,000	118,000	119,000																											10,196,000	196,000	733,000	377,000	371,000	60,121,000
investments in other investments												-106,621,000	-98,377,000	-100,225,000	-70,571,000	-32,052,000	-54,531,000	-5,591,000	-8,138,000	-10,923,000	-181,822,000	-103,002,000	-89,960,000	-52,972,000	-33,847,000	-30,084,000	-22,144,000	-28,558,000	-106,463,000	-20,533,000	-116,003,000	-15,913,000			-1,468,000	-2,730,000	-1,332,000	-1,314,000	-4,065,000	-4,460,000	-1,947,000	-27,280,000	-2,968,000	-5,066,000	-1,113,000	-2,489,000	-1,069,000	-28,659,000	-2,555,000	-1,697,000	-593,000	0	-2,080,000	-34,000	-14,322,000		-10,800,000	-14,420,000	-13,855,000		-7,065,000	-11,501,000	-5,004,000		-3,300,000
proceeds from other investments												50,651,000	44,350,000	56,188,000	19,482,000	19,144,000	21,801,000	7,965,000	42,371,000	19,253,000	56,423,000	51,822,000	53,873,000	50,651,000	9,048,000	12,816,000	23,181,000	47,307,000	23,559,000	24,462,000	1,461,000	8,443,000	23,222,000	12,051,000	2,155,000	5,637,000	5,607,000	1,278,000	1,067,000	26,849,000	1,171,000	1,172,000	1,770,000	3,534,000	1,781,000	1,980,000	8,060,000	3,797,000	1,439,000	767,000	980,000	2,604,000	4,171,000	14,088,000	461,000	2,523,000	11,109,000	11,603,000	16,803,000	2,428,000	4,615,000	6,688,000	2,779,000		12,872,000	825,000	1,132,000		9,850,000	10,441,000	6,801,000
redemption of op units												0											-72,000				-56,000	-1,000	-722,000	0	-10,000
(recovery) impairment on direct financing leases
refund of acquisition deposit
receipts from dividend reinvestment plan																23,206,000	37,742,000	21,818,000	32,285,000	9,897,000	9,854,000	22,164,000	4,886,000	6,586,000	10,415,000	12,386,000	7,335,000	10,272,000	136,436,000	73,737,000	19,596,000	85,182,000	35,554,000	24,697,000	5,414,000	5,224,000	20,459,000	14,264,000	31,540,000		6,233,000	5,258,000	36,330,000		37,156,000	54,752,000	14,224,000		14,304,000	23,088,000	17,525,000		15,543,000	15,312,000	12,214,000		10,106,000	6,784,000	183,000					6,665,000	4,400,000			3,935,000	11,841,000	9,732,000	7,588,000
taxes paid on vested restricted stock
proceeds from credit facility borrowings																620,000,000	206,000,000	510,000,000	171,000,000	288,000,000	454,000,000	232,000,000	317,000,000	200,000,000	670,000,000	669,000,000	148,000,000	170,000,000	255,000,000	209,000,000	670,000,000	122,000,000	922,000,000	776,000,000	6,000,000	144,000,000	166,000,000	470,000,000	120,000,000		-100,000,000	46,000,000	155,000,000		180,000,000	47,000,000	45,000,000		115,000,000	57,000,000	117,000,000		43,000,000	265,000,000	6,000,000		20,500,000	84,000,000	34,000,000		63,000,000	166,500,000	74,300,000		54,000,000	30,000,000	15,400,000		186,000,000	29,000,000	19,200,000		12,200,000	121,000,000	47,000,000
payments on credit facility borrowings																-495,000,000	-706,000,000	-490,100,000	-289,000,000	-335,000,000	-314,000,000	-367,000,000	-252,000,000	-275,000,000	-460,000,000	-637,000,000	-215,000,000	-203,000,000	-502,000,000	-269,000,000	-370,000,000	-442,000,000			-91,000,000	-62,000,000	-433,000,000	-200,000,000	-446,000,000		-5,000,000	-41,000,000	-213,000,000		-80,000,000	-72,000,000	-290,500,000		-123,000,000	-73,000,000	-48,000,000		-121,000,000	-44,000,000	-100,100,000		-57,500,000	-93,000,000	-42,500,000		-131,000,000	-146,500,000	-40,300,000		-32,000,000	-147,000,000	-18,400,000
receipts of other long-term borrowings																0	492,710,000	0	2,275,000					0	0			0	698,173,000	0	350,000,000	250,000,000	598,302,000	300,000,000	689,822,000	0	247,828,000	0	594,320,000	0	0	0	59,355,000	0	0	0	400,000,000					583,214,000	0	0	196,556,000
payments of other long-term borrowings																-1,222,000				0	0	-1,721,000	-328,000	-325,000	-324,000	-1,251,821,000	-318,000	-315,000	-180,314,000	-311,000	-309,000				-347,883,000	-4,512,000	-35,542,000	-1,252,000	-201,238,000	-1,224,000	-1,210,000	-52,211,000	-59,997,000	-1,029,000	-983,000	-12,667,000	-176,007,000	-757,000	-620,000	-612,000	-604,000	-410,596,000	-528,000	0	-59,354,000						-435,000	0	-39,000,000
payments for exercised options and restricted stock																-708,000	-653,000	-916,000	-2,279,000	0	0	0	-1,654,000	-23,000	0	0	-2,120,000
effective yield receivable on mortgage notes																85,000	85,000	-171,000	-172,000	-179,000	-179,000	-356,000	-354,000	-366,000	-367,000	-598,000	-593,000	-512,000	410,000	200,000	-819,000	-906,000			-1,120,000	-1,147,000	-1,147,000	-265,000	-319,000	-341,000	-342,000	-529,000	-545,000	-561,000	-561,000	-559,000	-554,000	-409,000	-257,000
proceeds from direct financing lease and related trust																			86,743,000
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
interest – amortization of deferred financing costs
noncontrolling members' contributions to consolidated joint venture																0	0	0	228,000
impairment on direct financing leases																217,000	0	0	7,700,000	27,153,000
benefit from uncollectible accounts																				326,000	-2,015,000	564,000	7,814,000		8,590,000	2,673,000	2,404,000
interest - amortization of deferred financing costs and refinancing costs
income from unconsolidated joint venture
cash acquired in acquisition
investments in direct financing leases																								-232,000	-2,184,000	-2,538,000	-2,229,000
interest - amortization of deferred financing costs																	2,277,000	2,238,000	2,238,000		2,238,000	2,242,000	2,243,000
acquisition of real estate or other																			-5,879,000
distributions from unconsolidated joint venture in excess of earnings																			1,103,000
net proceeds (costs) from issuance of common stock																			76,547,000
amortization of acquired in-place leases - net																				-3,189,000	-2,241,000	-2,590,000	-2,687,000	-2,809,000	-2,899,000	-3,106,000	-3,096,000	-3,034,000	-3,047,000	-3,610,000	-4,300,000	-9,582,000			-1,192,000	-1,207,000	-1,208,000	-1,284,000	-1,287,000		-1,318,000	-1,199,000	-1,304,000		-1,236,000	-1,426,000	-1,426,000
proceeds from sale of direct financing lease																				4,032,000	1,514,000
investments in unconsolidated joint venture
distributions from unconsolidated joint venture																					668,000	1,859,000	1,880,000	1,209,000	1,225,000	1,154,000	8,587,000
cash acquired																									0
impairment loss on real estate properties																							4,914,000	63,460,000	17,837,000	10,135,000	7,638,000																							0	24,971,000		0				89,000	0	70,000		170,000	0	1,514,000
net (costs) proceeds from issuance of common stock																							-29,000
distributions to op unit holders																							-5,885,000				-5,554,000	-5,441,000	-5,387,000	-5,220,000	-5,131,000	-5,038,000
adjustments to reconcile net income to net cash from operating activities:
impairment loss on direct financing leases																								231,000
provisions for uncollectible accounts
refinancing costs and amortization of deferred financing costs																								2,243,000	2,228,000	12,738,000	2,502,000
change in operating assets and liabilities – net of amounts assumed/acquired:
acquisition of real estate – net of liabilities assumed and escrows acquired																												0	-336,900,000	-206,744,000	-416,104,000	-5,892,000			-6,300,000	-84,189,000	-25,500,000	-17,300,000	-4,700,000	-30,115,000				-163,962,000	-205,739,000	-25,070,000	-1,852,000	-86,606,000	0			0	0
cash acquired in acquisition/merger
proceeds from sale of direct financing lease assets																								232,000
proceeds from sale of real estate investments																								188,024,000	5,727,000	18,213,000	45,848,000	104,857,000	20,974,000	41,380,000	2,392,000	2,000	14,695,000	26,591,000	255,000			293,000	3,631,000	4,000	0			4,829,000	2,188,000	7,938,000	14,068,000	1,000,000				0	53,000	0	28,000	777,000	0			9,000	28,866,000	0	3,027,000	2,788,000	0	2,571,000	3,683,000	879,000	870,000			34,576,000	942,000	18,064,000	6,931,000
increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash at beginning of year
cash, cash equivalents, and restricted cash at end of year
effect of foreign currency translation on cash and cash equivalents																									247,000	0	162,000	15,000	271,000	-97,000	-105,000	-114,000	-150,000
increase in cash and cash equivalents																									3,287,000	-19,318,000	-53,338,000	61,189,000	-663,000	23,649,000	4,088,000	-9,781,000	-9,685,000	-675,030,000	695,654,000	4,037,000	-28,237,000	8,315,000	17,758,000	-65,141,000	60,718,000	-18,572,000	23,900,000	-5,240,000	4,090,000	144,000	2,366,000	-10,379,000			-3,540,000	5,729,000	-765,000	-73,237,000	73,024,000	1,524,000	-4,277,000	-5,292,000	10,006,000	-3,581,000	1,625,000	649,000	-463,000			-171,000	1,926,000					3,180,000			-2,237,000
cash and cash equivalents at beginning of period																									0	0	93,687,000		0	0	5,424,000		0	0	4,489,000		0	0	2,616,000		0	0	1,711,000		0	0	351,000		0	0	6,921,000		0	0	2,170,000		0	0	209,000		0	0	1,979,000		0	0	729,000		0	0	3,948,000		0	0	12,083,000
cash and cash equivalents at end of period																									3,287,000	-19,318,000	40,349,000		-392,000	23,552,000	9,407,000		-9,835,000	-674,989,000	700,143,000		-28,237,000	8,315,000	20,374,000		60,718,000	-18,572,000	25,611,000		4,090,000	144,000	2,717,000		5,734,000	1,615,000	3,381,000		-765,000	-73,237,000	75,194,000		-4,277,000	-5,292,000	10,215,000		1,625,000	649,000	1,516,000		-1,876,000	-171,000	2,655,000			13,650,000	403,000		234,000	-9,312,000	9,846,000
proceeds from direct financing leases
accounts receivable																											-21,377,000				560,000	-67,000	-814,000	1,325,000	-196,000	-12,000	-3,164,000	1,343,000	-431,000	928,000	-208,000	-488,000	635,000	-441,000	-175,000	194,000	176,000	-1,818,000	339,000	109,000	-93,000	1,988,000	-652,000	-1,471,000	90,000		75,000	321,000	-177,000		2,792,000	-2,875,000	746,000		-195,000	-1,389,000	1,406,000
deposit to acquire real estate																															-113,816,000
benefit from uncollectible mortgages, notes and accounts receivable																												5,878,000			5,124,000	7,579,000			-2,000	-7,000	-15,000				2,321,000																																0
cash acquired in merger																																0	0
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
interest paid during the year, net of amounts capitalized
taxes paid during the year
adjustment to reconcile net income to cash from operating activities:
benefit from impairment on real estate properties																													17,275,000	6,893,000	34,558,000	3,040,000	1,743,000	6,916,000	5,982,000	0	2,102,000																																0	0	121,000		5,454,000
amortization of deferred financing costs and refinancing costs																													4,317,000	2,210,000	2,430,000	22,430,000	1,857,000
stock-based compensation																													3,673,000	3,665,000	2,778,000		2,199,000	2,873,000	1,610,000
accounts receivable – net																													-653,000
investment in construction in progress																													-17,153,000	-10,644,000	-16,316,000	-18,950,000			-5,851,000
investment in direct financing leases																													-1,049,000			0
escrow deposit for other long-term borrowing
payments for exercised options and restricted stock – net																													-21,023,000						-1,906,000	-1,995,000	-639,000	-413,000	-530,000
interest paid during the period, net of amounts capitalized																													42,159,000	37,413,000	36,597,000		29,463,000	35,244,000	25,829,000	34,643,000	25,898,000	24,135,000	26,243,000		24,451,000	25,305,000	26,092,000		23,800,000	24,160,000	22,163,000		17,495,000	21,491,000	16,896,000		20,255,000	13,695,000	7,814,000		6,866,000	11,168,000	6,474,000		7,181,000	12,142,000	7,437,000
provision (recovery) for uncollectible mortgages, notes and accounts receivable
payments for exercised options and restricted stock - net																															-2,381,000
restricted stock amortization expense																																				2,022,000	2,022,000	2,285,000	2,263,000	1,509,000	1,509,000	1,472,000	1,452,000	1,486,000	1,485,000	1,486,000	1,485,000	1,519,000	1,520,000	1,519,000	1,479,000	455,000	450,000	467,000	839,000	479,000	480,000	479,000	480,000	526,000	526,000	525,000	526,000	545,000	546,000	308,000	26,000	293,000	3,639,000	292,000	293,000	285,000	285,000	286,000	285,000
payments on other long-term borrowings
escrow deposit for other long-term borrowings
non-cash investing and financing activities:
non- cash investing activities
non-cash acquisition of business
total
non-cash financing activities
assumed aviv debt
stock exchanged in merger
op units exchanged in merger
amortization of deferred financing and debt extinguishment costs																																			10,730,000	1,321,000			2,962,000				682,000		673,000
non-cash financing activities:
accrued dividends																																			50,221,000
other																																												-550,000	-38,000	-37,000	-38,000	-38,000	-37,000	-37,000	-38,000	20,000	-38,000	23,000	-98,000	-52,000	-43,000	-43,000	-43,000	-47,000	-47,000	-47,000	-47,000	-37,000	-17,000	-170,000	-72,000					11,000	-16,000	-1,429,000	-87,000
proceeds from sale of real estate investments – net																																				23,000
proceeds from term loan																																								0
deposit for proposed capital lease
amortization of deferred financing and debt extinguishment costs/
(gain)/loss on assets sold – net
cash flow from operating activities
provisions for uncollectible mortgages, notes and accounts receivable
amortization of deferred financing cost and refinancing
straight-line rent																																										-7,692,000	-6,010,000	-5,659,000	-6,625,000	-6,579,000	-6,541,000	-2,664,000	-3,224,000	-3,269,000	-3,403,000	-4,282,000	-2,967,000	-2,015,000	-1,946,000		-2,253,000	-2,343,000	-2,391,000		-3,546,000	-2,544,000	-1,869,000		-2,298,000	-2,191,000	-7,257,000
lease inducement																																										843,000	842,000	842,000	843,000	842,000	842,000	842,000	842,000	941,000	755,000	255,000	-25,000	40,000	-276,000		133,000	-171,000	570,000		-4,895,000	818,000	818,000		119,000	472,000	758,000
operating assets and liabilities for owned and operated properties																																																-197,000	0	51,000	-98,000	-700,000	2,965,000	-125,000	81,000		-506,000	2,488,000	5,977,000
cash flow from investing activities
capital improvements and funding of other investments																																											-8,328,000	-9,330,000	-5,899,000	-6,222,000	-7,985,000	-7,585,000	-3,894,000	-3,793,000	-4,325,000	-10,367,000	-8,655,000	-7,864,000	-9,139,000	-8,592,000	-7,115,000	-4,405,000	-3,120,000	-4,264,000	-4,200,000	-3,660,000	-5,334,000	-3,087,000	-1,444,000	-2,451,000	-1,568,000					-1,072,000	-1,411,000	-11,000	-1,327,000
collection of mortgage principal – net																																												12,322,000	119,000	124,000	119,000	20,000	17,000	17,000	20,000	18,000	15,000	15,000	30,000		137,000	133,000	133,000		233,000	226,000	222,000		190,000
cash flow from financing activities
proceeds from credit line borrowings
payments of credit line borrowings
receipts from dividend reinvestment plan – net
redemption of preferred stock																																																0	0	-4,000	-108,552,000																					-13,000	0
amortization of deferred financing and debt extinguishment (gain)/costs																																									699,000
amortization of deferred financing and refinancing costs																																															7,737,000	648,000	3,700,000				978,000
gain on sale of securities																																																				0	0
provisions for uncollectible accounts receivable
payments from exercised options and restricted stock – net																																																	0	0	-1,254,000
investment in purchase option
payment of financing related costs																																																		-107,000	-534,000	-22,348,000	-407,000	-4,533,000	-4,291,000		-215,000
provisions for uncollectible mortgages, notes, and accounts receivable
amortization of in-place leases																																																	-1,408,000	-1,616,000	-1,616,000
non-cash investing activities
assumed debt obligations
non-cash settlement of mortgage obligations
non-cash acquisition of real estate properties
stock consideration issued for acquisition
net non-cash investing activities
decrease in cash and cash equivalents
amortization of deferred financing costs																																																			694,000				978,000		690,000	500,000	500,000		500,000	500,000	500,000		500,000	500,000	459,000		439,000	431,000	643,000		539,000
amortization of straightline mortgage interest income																																																			-421,000
income from accretion of marketable securities to redemption value																																																												-52,000	-52,000	-51,000	-52,000	-52,000	-52,000	-51,000	-52,000
refinancing costs																																																								0	0											0	0	0	3,485,000
income tax liabilities
repurchase of preferred stock
amortization of other non-cash interest charges
payments from exercised options – net																																																					0	85,000	4,000
change in operating assets and liabilities:
impairment
amortization for deferred financing costs																																																																											506,000
gain on assets and equity securities sold - net
net change in accounts receivable																																																																								-1,106,000	-738,000	601,000	940,000
net change in straight-line rent
net change in lease inducement
net change in income tax liabilities
net change in other operating assets and liabilities
net change in operating assets and liabilities for owned and operated properties
investments in other investments– net
payment of financing costs
receipts/(payments) for exercised options and restricted stock – net
uncollectible accounts receivable																																																													0
tax liabilities
payments from exercised options and taxes on restricted stock – net
offering costs for equity shelf program – net of proceeds from issuance of common stock
payments/proceeds from common stock offering – net
(gains) losses on assets sold and equity securities – net																																																															-477,000
gain on investment restructuring
adjustment of derivatives to fair value
net change in other assets																																																																				617,000	343,000	-176,000	1,774,000	1,988,000	1,952,000	2,991,000	-2,856,000
proceeds from sale of equity securities
payment to trustee to redeem long-term borrowings
receipts/(payments) for exercised options – net
proceeds from common stock offering
payment on common stock offering
operating activities
gains on assets sold and equity securities – net																																																													-11,806,000
other assets																																																													-4,144,000	394,000	-1,276,000		575,000	824,000	-1,371,000
other assets and liabilities																																																													1,239,000	-1,665,000	1,464,000				-502,000
owned and operated
prepayment of re-financing penalty
receipts/(payments) from dividend reinvestment plan																																																													10,221,000	10,189,000	10,096,000
receipts/(payments) from exercised options and taxes on restricted stock – net																																																													0	0	-2,087,000		0
net proceeds from common stock offering																																																													97,148,000				0
provisions for impairment																																																																											3,700,000
benefit from impairment on equity securities																																																																								0	0
amortization for deferred finance costs
proceeds from other investments and assets held for sale – net
payment of re-financing related costs
change in fair value of derivatives
other liabilities																																																																	1,231,000
proceeds from sale of stock																																																																				0
receipts from other long-term borrowings																																																																					0	0	39,000,000
financing costs paid																																																																	-3,000	-101,000	-591,000
interest paid during the period																																																																	7,118,000	11,957,000	8,609,000		8,798,000	10,960,000	1,684,000		5,082,000	9,871,000	3,996,000
(gains) losses on assets sold and equity securities - net																																																																			-1,597,000
collection of mortgage principal - net																																																																			184,000
receipts/(payments) from exercised options and taxes on restricted stock - net																																																																			-809,000
proceeds from other investments and assets held for sale - net
investments in other investments- net
proceeds from sale of interest rate cap
receipts/(payments) for exercised options - net
proceeds from preferred stock offering
interest paid during the year
net change in tax liabilities
net change in operating assets and liabilities																																																																					5,413,000	-1,811,000	4,519,000	-1,924,000	2,690,000	-7,561,000	4,433,000
receipts/(payments) from exercised options – net
deferred financing costs paid																																																																								-4,994,000	0	-165,000	-168,000
loss on assets sold - net																																																																						133,000	248,000		-710,000	4,165,000	37,000
cash in transit from sale
receipts/(payments) from exercised options - net																																																																						0	225,000
(gain) loss on assets sold - net
receipts from dividend reinvestment plan and directors fees																																																																								4,457,000	1,683,000	658,000	149,000
payments for exercised options - net
proceeds from other investments - net																																																																									497,000	498,000	764,000
investments in other investments - net																																																																									-270,000	-5,586,000	-311,000
payment on credit facility borrowings																																																																									-33,000,000	-19,500,000	-62,000,000
receipts from exercised options																																																																									104,000	87,000	133,000
payments of exercised options																																																																									-278,000	-439,000	-591,000
cost of raising capital																																																																									0	-13,000	-28,000
payments for exercised options

We provide you with 20 years of cash flow statements for Omega Healthcare Investors stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Omega Healthcare Investors stock. Explore the full financial landscape of Omega Healthcare Investors stock with our expertly curated income statements.

The information provided in this report about Omega Healthcare Investors stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.